Publications by authors named "Kate M Webber"

Claim this Profile
T
Targeting gonadotropins: an alternative option for Alzheimer disease treatment.
Gemma Casadesus, Emma Ramiro Puig, Kate M Webber, Craig S Atwood, Margarida Castell Escuer

J Biomed Biotechnol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.
Sandra L Siedlak, Gemma Casadesus, Kate M Webber, Miguel A Pappolla, Craig S Atwood

Free Radic Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menopause, estrogen, and gonadotropins in Alzheimer's disease.
Gemma Casadesus, Raj K Rolston, Kate M Webber, Craig S Atwood, Richard L Bowen

Adv Clin Chem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease.
Akanksha Thakur, Sandra L Siedlak, Sheronica L James, David J Bonda, Akanksha Rao, Kate M Webber

Int J Clin Exp Pathol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for the role of luteinizing hormone in Alzheimer disease.
Kate M Webber, Gemma Casadesus, Richard L Bowen, George Perry, Mark A Smith

Endocr Metab Immune Disord Drug Targets· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contribution of luteinizing hormone to Alzheimer disease pathogenesis.
Kate M Webber, George Perry, Mark A Smith, Gemma Casadesus

Clin Med Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increases in luteinizing hormone are associated with declines in cognitive performance.
Gemma Casadesus, Erin L Milliken, Kate M Webber, Richard L Bowen, Zhenmin Lei

Mol Cell Endocrinol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gonadotropins: a cohesive gender-based etiology of Alzheimer disease.
Kate M Webber, Gemma Casadesus, Craig S Atwood, Richard L Bowen, George Perry

Mol Cell Endocrinol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease.
Kate M Webber, Douglas M Stocco, Gemma Casadesus, Richard L Bowen, Craig S Atwood

Mol Neurodegener· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.
Gemma Casadesus, Matthew R Garrett, Kate M Webber, Anthony W Hartzler, Craig S Atwood

Drugs R D· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice.
Gemma Casadesus, Kate M Webber, Craig S Atwood, Miguel A Pappolla, George Perry

Biochim Biophys Acta· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target.
Kate M Webber, Gemma Casadesus, Xiongwei Zhu, Mark E Obrenovich, Craig S Atwood

Curr Pharm Des· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis.
Kate M Webber, Gemma Casadesus, George Perry, Craig S Atwood, Richard Bowen

Alzheimer Dis Assoc Disord· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cell cycle in Alzheimer disease: a unique target for neuropharmacology.
Kate M Webber, Arun K Raina, Michael W Marlatt, Xiongwei Zhu, María I Prat

Mech Ageing Dev· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic opportunities in Alzheimer disease: one for all or all for one?
Michael W Marlatt, Kate M Webber, Paula I Moreira, Hyoung-gon Lee, Gemma Casadesus

Curr Med Chem· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis.
Kate M Webber, Gemma Casadesus, Michael W Marlatt, George Perry, Clive R Hamlin

Ann N Y Acad Sci· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease.
Kate M Webber, Mark A Smith, Hyoung-gon Lee, Peggy L Harris, Paula Moreira

J Neurosci Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease.
Gemma Casadesus, Xiongwei Zhu, Craig S Atwood, Kate M Webber, George Perry

Curr Drug Targets CNS Neurol Disord· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection.
Kate M Webber, Richard Bowen, Gemma Casadesus, George Perry, Craig S Atwood

Acta Neurobiol Exp (Wars)· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis